Marketing-authorisation holder · Canada
Xediton Pharmaceuticals Inc
17 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
17 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BAXDELA450 mg · Tablet | Delafloxacin | Canada | Marketed | 2026 |
| BAXDELA300 mg / vial · Powder For Solution | Delafloxacin | Canada | Marketed | 2026 |
| LEVODEXA0.1 % / w/v + 0.5 % / w/v · Solution | Dexamethasone, Levofloxacin | Canada | Marketed | 2025 |
| ORITINIV1200 mg / vial · Powder For Solution | Oritavancin | Canada | Authorised | |
| ORITINIV400 mg / vial · Powder For Solution | Oritavancin | Canada | Authorised | |
| RIDAURA3 mg · Capsule | Auranofin | Canada | Marketed | 1993 |
| VABOMERE1 g / vial + 1 g / vial · Powder For Solution | Meropenem, Vaborbactam | Canada | Marketed | 2025 |
| VIMOVO20 mg + 375 mg · Tablet (Immediate- And Delayed-Release) | Esomeprazole, Naproxen | Canada | Marketed | 2011 |
| VIMOVO20 mg + 500 mg · Tablet (Immediate- And Delayed-Release) | Esomeprazole, Naproxen | Canada | Marketed | 2011 |
| VISKAZIDE25 mg + 10 mg · Tablet | Hydrochlorothiazide, Pindolol | Canada | Not marketed | 1983 |
| VISKAZIDE50 mg + 10 mg · Tablet | Hydrochlorothiazide, Pindolol | Canada | Not marketed | 1983 |
| VISKEN5 mg · Tablet | Pindolol | Canada | Not marketed | 1978 |
| VISKEN10 mg · Tablet | Pindolol | Canada | Not marketed | 1978 |
| ZOMIG2.5 mg · Tablet | Zolmitriptan | Canada | Marketed | 1998 |
| ZOMIG NASAL SPRAY5 mg / act · Spray | Zolmitriptan | Canada | Marketed | 2004 |
| ZOMIG NASAL SPRAY2.5 mg / act · Spray | Zolmitriptan | Canada | Marketed | 2004 |
| ZOMIG RAPIMELT2.5 mg · Tablet (Orally-Disintegrating) | Zolmitriptan | Canada | Marketed | 2001 |